I completed my Pharm.D in 2017 at Aix-Marseille University. I am currently a PhD student in PKPD modelling. My project focuses on in silico optimization of FOLFIRINOX regimen applied to pancreatic cancer. The aim is to define a new administration protocol to achieve over standard regimen, both, better efficacy and safety profiles. To do so several steps are needed: patient data collection, PKPD Tox model development and validation of the new FOLFIRINOX protocol that can forward be tested in vitro and in vivo.